An interventional study of cardiovascular MRI (CMR) and Conventional Cardiologic Evaluation in Heart Disease, sponsored by NYU Langone Health. Suspended at 1 site in United States. Open to participants aged 7 Years to 95 Years. Per ClinicalTrials.gov, last updated 2026-01-05.
Sponsored by NYU Langone Health · Not applicable, Interventional, and Diagnostic
The purpose of this investigation is to evaluate newer methods of performing cardiovascular MRI (CMR) that will provide new kinds of information related to the interplay between the cardiac and the respiratory cycles, such as the interaction between the left ventricle and the right ventricle during respiration . The primary statistical objective is to provide preliminary indications of the relative utility of the investigational imaging software in terms of image quality and suitability for routine clinical use. Image quality will be expressed in terms of signal-to-noise ratios (SNR), contrast-to-noise ratios (CNR) and subjective Likert-type qualitative assessments independently provided by each of multiple blinded readers for each image. Suitability for routine use will be assessed in terms of imaging time and a binary indicator of whether, in the opinion of the investigator, adverse procedural complications (not expected) were encountered during a given imaging session.
3,639 studies on the registry are indexed under Heart Diseases; 461 are open to participants now.
This study's planned enrollment of 100 is close to the median of 100 across 1,778 interventional studies indexed under Heart Diseases.
Browse Heart Diseases studies →NYU Langone Health is the lead sponsor of 1,391 studies on the registry; 254 are open to participants now.
Of its 227 completed or terminated interventional studies of FDA-regulated products, 191 (84%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
70 with a history of heart or lung disease
Procedure: cardiovascular MRI (CMR)
30 without any history of heart or lung disease
Procedure: Conventional Cardiologic Evaluation
CMR is used to demonstrate cardiac abnormalities and assess cardiac function in many patients
ECG (gating), and respiratory motion effects
Image Quality measured by resolution
Time frame: 10 Minutes
Image Quality measured by signal to noise
Time frame: 10 Minutes
Suitability for routine use measured by imaging time and ease of use
Time frame: 10 Minutes
This study is suspended, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
NYU Langone Health